Hemant Surgical Industries Limited submitted a revised disclosure to BSE Limited regarding its Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon, USA. The revision was made at the request of Sonomed Escalon and for better investor understanding, with minor modifications to the original disclosure dated March 31, 2026.
The disclosure was made pursuant to SEBI Circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and includes the following material details:
Agreement Details:
- Party: Sonomed Escalon, USA
- Purpose: To undertake Semi Knocked Down (SKD) manufacturing in India of two designated models of A-scan and pachymetry ophthalmic ultrasound devices for distribution exclusively within the Indian Market
- Shareholding: Nil
- Significant Terms: Not applicable
- Related Party Status: The promoter was previously an authorized distributor of Sonomed Escalon, but the parties are not currently related. The transaction does not fall within related party transactions.
Financial Terms:
- Sonomed Escalon agrees to supply components in SKD form at a preferential "Transfer Price"
- Pricing is exclusive of taxes, duties, customs, statutory levies, and shipping costs (unless otherwise agreed)
- No issuance of shares, loans, or financial instruments is involved in this agreement
Regulatory Context:
- This is a revised disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- The original disclosure was made on March 31, 2026
- The company confirmed there are no special rights, nominee directors, potential conflicts of interest, or amendments to report
The agreement represents a manufacturing partnership for ophthalmic medical devices specifically for the Indian market, with clear territorial exclusivity and defined supply terms.